Navigation Links
Canadian scientists link fat hormone to death from potentially deadly blood infection
Date:10/23/2009

A new Canadian study has found that lower-than-normal levels of a naturally-occurring fat hormone may increase the risk of death from sepsisan overwhelming infection of the blood which claims thousands of lives each year.

The study by researchers at St. Michael's Hospital and the University of Toronto focused on adiponectin, a hormone secreted by visceral fat surrounding the abdominal organs. The findings were presented this week at the 2009 Clinical Congress of the American College of Surgeons held in Chicago.

Using an animal model designed to mimic what occurs in people with low levels of adiponectin, the scientists observed that:

o Mice with low levels of the hormone were at much greater risk of dying from a blood infection. o Sepsis could be prevented if the animals were given additional adiponectin.

The risk of dying from sepsis after surgery is known to be two-and-a-half to three times higher in people with "metabolic syndrome"a combination of factors including abdominal obesity, high blood fat composition, high blood pressure, diabetes, and high inflammatory and blood clot indicators. People with these conditions tend to have lower levels of adiponectin which may prime them to greater sepsis related complications.

"We hypothesized that low adiponectin levels might predispose such individuals to develop sepsis and sepsis-related problems," says Dr. Subodh Verma, a cardiac surgeon at St. Michael's Hospital and associate professor of surgery at the University of Toronto who holds the Canada Research Chair in Atherosclerosis. "This initial hypothesis was borne out by our latest research."

Dr. Verma and his colleagues believe the implications of their study are two-fold: first, low adiponectin levels may help predict which patients are vulnerable to sepsis-related inflammation and are at a greater risk of dying from sepsis; second, treatment strategies or approaches that cause an increase in adiponectin levels may lower a person's risk of death from severe sepsis.

Any discovery that might help predict or prevent sepsis-related death would be welcome, Dr. Verma adds, particularly since in certain parts of North America, 40 to 50 percent of the population has the major risk factors of metabolic syndrome. "We need treatments that are going to be effective and hopefully, reduce mortality rates in this high-risk population," he says.

Dr. Verma and his colleagues are hoping to be the first group to conduct studies of adiponectin in humans. They are currently seeking approval to mount a small clinical trial where a purified form of adiponectin will be given to patients in the early stages of sepsis. If the treatment is found to be safe, a larger trial may follow, says Dr. Verma.


'/>"/>

Contact: Julie Saccone
sacconej@smh.toronto.on.ca
416-864-5047
St. Michael's Hospital
Source:Eurekalert

Related medicine news :

1. Canadian Cardiovascular Society recognizes trailblazing work by U of Alberta heart researcher
2. Researcher, physician and teacher Phil Gold to be inducted into the Canadian Medical Hall of Fame
3. Canadian blood supply future uncertain as population ages: Study
4. Canadian researchers discover the first-ever link between intelligence and curiosity
5. Queens study to test Canadian guidelines for daily exercise
6. Elsevier and Canadian College of Health Service Executives announce new publishing partnership
7. NeuroVasx Receives Canadian Approval for cPAX Aneurysm Treatment System
8. Canadians Travel to Detroit Town Meeting to Talk About Their Health Care
9. The National Health Care Anti-Fraud Association Signs Memorandum of Understanding With Canadian and European Anti-Fraud Organizations
10. Narconon Trois-Rivieres Cites Hillbilly Heroin as Canadian Drug Addiction Crisis
11. Canadian Bio Med Attacks Worlds Leading Cause of Blindness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... , ... “Journey to the Light: The Quest for Happiness and Love. . ... to finding herself. “Journey to the Light: The Quest for Happiness and Love. ... writer of newsletters, manuals, and articles, who has recently decided to expand her literary ...
(Date:7/23/2017)... (PRWEB) , ... July 23, 2017 , ... A ... in St. Louis, and led by the Minneapolis Veterans Administration Health Care System overwhelmingly ... of the disease offers very few benefits. , In the cases involved with ...
(Date:7/23/2017)... ... 23, 2017 , ... Technology is making it easier for ... tools are helping patients become more actively involved in their care and maintaining ... survey, released today by the American Hospital Association’s (AHA) Health Forum. , According ...
(Date:7/23/2017)... ... July 23, 2017 , ... Viora Ltd., a ... US Patent No. 9,038,640 by the United States Patent and Trademark Office. The ... combination of Switching, Vacuum, and Cooling mechanisms to further increase the efficacy and ...
(Date:7/21/2017)... ... July 21, 2017 , ... "As a doctor of lung medicine ... catheters available on the market," said an inventor from Center Valley, Pa. "My idea ... the patient." , He developed the patent-pending PLEURAL SAFE-t-STAT CATHETER KIT to offer an ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/10/2017)... , July 10, 2017 The Institute for ... methods, is the recipient of a VITROCELL® inhalation exposure ... International Science Consortium. The device, which is designed to ... expose human lung cells to airborne test materials in ... use the VITROCELL® system for testing combustible tobacco products, ...
(Date:7/5/2017)... 5, 2017 Wolfmet 3D  printed tungsten collimator manufactured by ... and manufacturing combine to progress molecular radiotherapy imaging. ... are unable to accurately quantify the radiation absorbed by those ... the success of this radiotherapy treatment has been available — ... ...
Breaking Medicine Technology: